Skip to main content
SL

STICTA Labs

STICTA Labs uses precision fermentation to engineer microorganisms for the cost-effective and sustainable production of specialized proteins and metabolites. Their AI-driven platform accelerates development and optimizes microbial strains, providing industries with efficient pathways to create complex molecules for cell culture and agriculture.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional methods for producing proteins and metabolites are often costly, inefficient, and unsustainable. This limits the accessibility of high-value compounds for various industries and hinders the development of more environmentally conscious processes.

Solution

STICTA Labs leverages precision fermentation to engineer microorganisms, enabling the cost-effective and sustainable production of specialized proteins and metabolites. Our platform utilizes advanced bioscience and AI-driven optimization to accelerate the development lifecycle from research to commercialization. By transforming microorganisms, we facilitate the efficient creation of complex molecules, offering industries a pathway to innovation and improved sustainability. We focus on delivering economically viable solutions tailored to specific market needs, driving progress in sectors like cell culture and agriculture.

Target Audience

Our primary customers are companies in the cell culture, biopharmaceutical, and agricultural sectors seeking to improve the efficiency, cost-effectiveness, and sustainability of their protein and metabolite production.

Features

  • Precision fermentation platform for engineered microorganism development.
  • AI-driven optimization of microbial strains for enhanced protein and metabolite production.
  • Development of high-value recombinant proteins and metabolites for industrial applications.
  • Focus on cost reduction and sustainability in bioproduction processes.
  • Specialized solutions for cell culture, including thermostable and cost-effective insulin analogs for serum-free media.
  • Development of customized transferrins for optimized cell growth and yield in various cell types.
  • BioSolutions for agriculture aimed at enhancing crop yields through natural growth regulators and bioactive compounds.
  • Proteome-constrained genome-scale modeling for identifying and addressing inefficiencies in cellular production systems.
  • Streamlined transition from laboratory-scale proof-of-concept to large-scale manufacturing.
This profile is AI-generated and may contain inaccuracies.